Financials
- Market Capitalization 1.88 B
- Employee 524
- Founded 2008
- CEO Bahija Jallal
- Website www.immunocore.com
- Headquarter United Kingdom
- FIGI BBG00YYCXFB9
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-83.55
ratio cours/chiffre d'affaires
3.77
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 2027 | NBTX Nanobiotix S.A. - ADSs | 39.12 USD | -3.74% | -6.23% | +4.13% | +371.89% | 1.89 B USD | ||
| 2028 | MRVI Maravai LifeSciences Holdings, Inc. - Class A common stock | 7.30 USD | -4.45% | -16.95% | +10.61% | +205.44% | 1.90 B USD | ||
| 2041 | TSHA Taysha Gene Therapies, Inc. - Common Stock | 5.75 USD | +1.05% | -8.15% | -2.38% | +98.28% | 1.87 B USD | ||
| 2064 | RXRX Recursion Pharmaceuticals, Inc. - Class A Common Stock | 3.34 USD | -1.76% | -6.18% | +10.23% | -27.23% | 1.79 B USD |